RxDoctor Payments Data

Sheryl Mulder

Nurse Practitioner · Ottumwa, IANPI 1962497438

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (58.7%), speaking fees and education — rather than concentrated in one kind of arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 20.8%. 2025 is the largest year on record at $4,050, 7.9 times the $512 reported in 2021. Among nurse practitioner clinicians in IA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$8,085in general payments, 2019–2025

Across 221 payments — averaging $36.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • LNHC, Inc$2K
  • E.r. Squibb & Sons, L.L.C.$1K
  • Johnson & Johnson$813
  • Sun Pharmaceutical Industries Inc.$741
  • AbbVie$738
  • Galderma Laboratories, L.p.$504
  • plus $3K from 19 others

What the payments were for

  • Consulting fees$6448%
  • Speaking & faculty fees$1,60020%
  • Travel & lodging$3204%
  • Food & beverage$4,74859%
  • Education$77310%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,085 in reported general payments places this provider in the 95th percentile of 1,346 nurse practitioner providers in Iowa.

See all nurse practitioner providers in Iowa

Medicare billing

Part B allowed, 2024
$229,147
Medicare patients
1,001
Services billed
17,052

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tacrolimus30$5,562
Acitretin14$4,061
Fluocinonide80$2,721
Metronidazole38$2,514
Ketoconazole115$1,747
Triamcinolone Acetonide210$1,588
Doxycycline Monohydrate78$1,560
Clindamycin Phosphate31$1,536
Clobetasol Propionate21$1,217
ValacyclovirValacyclovir Hcl25$747
ProgesteroneProgesterone, Micronized12$704
Spironolactone14$617
Nystatin23$376
Silver Sulfadiazine20$223
Mupirocin31$194

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Ottumwa

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →